Intraperitoneal chemotherapy is a treatment for cancers in the abdomen or belly area. This treatment delivers anti-cancer drugs directly into the peritoneal cavity, the area in the belly that contains ...

In patients with tumors confined to the peritoneal cavity, there is established pharmacokinetic and tumor biology-related evidence that intraperitoneal drug administration is advantageous. Three large ...

Intraperitoneal chemotherapy was associated with long-term survival benefits compared with IV chemotherapy in patients with advanced ovarian cancer, according to retrospective study results. The ...

Oncologist Don Dizon explains the advantages of intraperitoneal therapy and why further research and education are necessary to bring it to the forefront of ovarian cancer treatment. Intraperitoneal ...

Safety and efficacy of PIPAC in patients with ovarian cancer with peritoneal metastases: A first-in-US phase I study. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This ...

In clinical practice, only a few risk factors remain that can be modified based on the decisions of patients and their physicians. The surgical decision making and chemotherapy administration choices, ...

Pressurized intraperitoneal aerosol chemotherapy, or PIPAC, is a new treatment technique that gives chemotherapy in the form of a pressurized aerosol, or spray, directly into the abdominal cavity.

Surgery and standard intravenous chemotherapy with a platinum-taxane combination induces complete remission in the majority of patients with newly diagnosed ovarian cancer. Most patients will ...

HIPEC surgery is a promising treatment option for patients with certain abdominal cancers. Surgical oncologist Erin Ward, MD, discusses which patients would be best candidates for HIPEC, explains why ...

Women who received intraperitoneal chemotherapy after surgery for ovarian cancer had a reduced amount of disease progression when compared with those who received chemotherapy via IV. Intraperitoneal ...